Significant evidence suggests that cytokines and glucocorticoids are linked to a poorer prognosis in cancer patients [72–79].IL-6 and TNF-α play roles in all stages of tumor development, including formation, progression, and metastasis [77]. This evidence concerns the gene IL6 and neoplasm.